Freenome

Freenome

Outpacing cancer starts with early detection

Location
Roles tracked
0
In pipeline
0
Tracking since

At a glance

You're tracking 0 roles at Freenome. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
413 people
Headquarters
Brisbane, California
Founded
2014
Type
Privately Held
Total funding
$1.8B

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.

molecular diagnostics multiomics machine learning biotechnology cancer screening oncology early cancer detection and computational biology

Open roles at Freenome